Dr. Dylan Christopher Payne, DO

Dr. Payne practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Payne's NPI, 1194985218, was assigned on June 12, 2008. Dr. Payne graduated from At Still University of Health Sciences, College of Osteo Med, Kirksville in 2005. Dr. Payne holds New York license 250572.

Dr. Payne's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Dr. Payne's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Payne is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is Jefferson Hospital Counseling Services. Dmand AI also links Dr. Payne to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Payne practices, 7 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Payne's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Payne is licensed in New York.

CMS data shows 100 Medicare services from Dr. Payne across 3 procedure codes in 2024, for 48 Medicare patients. Medicare paid $6,183 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 48 Medicare patients who saw Dr. Payne in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have anxiety, and 75% have high blood pressure. 48% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Payne's median patient age at 55, with 53% women.

In 2024, Dr. Payne wrote 1,573 Medicare Part D claims for 80 patients. 94% of them were for generic drugs. CMS names the drug for 1,363 of them, across 38 drugs with 11 or more claims each, at $48,500 in total drug cost. In 2023, CMS named 1,212 claims across 33 drugs.

Dr. Payne accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 58 general payments to Dr. Payne from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Abbvie Inc. paid the most, $380.

Dr. Payne graduated from At Still University of Health Sciences, College of Osteo Med, Kirksville in 2005.